NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY)
$0.6110
-0.0315 ( -8.26% ) 35.7K
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.
Market Data
Open
$0.6110
Previous close
$0.6425
Volume
35.7K
Market cap
$3.13M
Day range
$0.6080 - $0.6800
52 week range
$0.3611 - $9.0790
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Dec 19, 2024 |
8-k | 8K-related | 16 | Nov 22, 2024 |
10-q | Quarterly Reports | 94 | Nov 07, 2024 |
8-k | 8K-related | 17 | Nov 06, 2024 |
8-k | 8K-related | 16 | Oct 29, 2024 |
8-k | 8K-related | 14 | Oct 16, 2024 |
prem14a | Proxies and info statements | 8 | Sep 25, 2024 |
8-k | 8K-related | 18 | Sep 20, 2024 |
10-q | Quarterly Reports | 95 | Aug 13, 2024 |
8-k | 8K-related | 23 | Jul 29, 2024 |